- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07892066
Comparative Effects of Soft Tissue Mobilization and Pressure Therapy With and Without Dynamic Cupping on on Pain and Disability in Patients With Thoracic Back Pain
Comparison of Sequential Effects of Instrument Assisted Soft Tissue Mobilization and Transverse Oscillatory Pressure With and Without Directional Dynamic Cupping on Pain and Disability in Patients With Thoracic Back Pain
This study aims to compare the sequential effects of Instrument-Assisted Soft Tissue Mobilization (IASTM) and Transverse Oscillatory Pressure (TOP), with and without Directional Dynamic Cupping, in patients with thoracic back pain. The study will evaluate the effectiveness of these treatment approaches in reducing pain, improving functional ability, and minimizing disability during daily activities.
Studieoversikt
Status
Forhold
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Punjab Province
-
Lahore, Punjab Province, Pakistan, 54000
- University of Management & Technology
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Patients 25-45 years with non-specific chronic thoracic back pain
- Both male and female
- Mild to moderate thoracic back pain with a NPRS Scale score of 3-6 out 10
- Thoracic back pain lasting at least 3 months (12 weeks)
- Pain localized to the thoracic region (T1-T12) without radiating pain
- Willingness to provide informed consent and attend all treatment sessions
Exclusion Criteria:
- Diagnosed spinal pathological conditions like disc herniation, stenosis
- Presence of tumors, lung diseases, visceral diseases, or with red flag
- Referred pain associated with cervical or lumbar radiculopathy
- History of cardiorespiratory disease
- History of thoracic surgery or rib fracture fixation within the past 6 months
- Bleeding disorders or current use of anticoagulant medications
- Skin infection or hypersensitivity at the treatment area
- Pregnancy
- Body Mass Index (BMI) greater than 35 kg/m²
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Aktiv komparator: Instrument assisted soft tissue (IASTM), Transvers oscillatory pressure (TOP)
|
Participants will receive Instrument-Assisted Soft Tissue Mobilization (IASTM) and Transverse Oscillatory Pressure (TOP) in sitting or prone positions, combined with alternating 10-second resisted isometric trunk flexion-extension contractions. Conventional therapy includes a hot pack for 10 minutes and muscle stretching (10 repetitions, 30-second hold each). |
|
Eksperimentell: Instrument assisted soft tissue, Transvers oscillatory pressure and Directional dynamic cupping
|
Participants will receive a moist hot pack over the thoracic region for 10-15 minutes, followed by IASTM using the Graston tool for 5-8 minutes. Transverse Oscillatory Pressure (TOP) will be applied for 3-5 minutes per affected segment, according to patient tolerance. Directional Dynamic Cupping will then be performed over the thoracic paraspinal muscles for 5-10 minutes with controlled suction and gliding movements. |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Numerical Pain Rating Scale
Tidsramme: Baseline , 2 weeks and 4 weeks post treatment
|
The 11-point numeric with 0 representing No pain, 1-3 representing Mild Pain (nagging, annoying, interfering little with ADLs), 4-6 representing Moderate Pains (interferes significantly with ADLs), 7-10 representing Sever Pain (disabling, unable to perform ADLs). |
Baseline , 2 weeks and 4 weeks post treatment
|
|
Function Rating Index
Tidsramme: Baseline , 2 weeks and 4 weeks post treatment
|
The Functional Rating Index (FRI) consists of 10 items: pain intensity, pain frequency, sleep, personal care, travel, work, leisure activities, lifting, walking, and standing. Two items assess pain characteristics, while eight assess spinal functional limitations in daily activities. Each item is scored from 0 (no pain/full function) to 4 (maximum pain/total disability), with higher scores indicating greater disability. |
Baseline , 2 weeks and 4 weeks post treatment
|
|
Bubble Inclinometer
Tidsramme: Baseline , 2 weeks and 4 weeks post treatment
|
Lumbar range of motion (ROM) will be measured in standing using bubble inclinometers, with S1 and T12 as reference points for flexion and extension, and T12 for lateral flexion. Two inclinometers will assess forward flexion, while one will assess extension and lateral flexion; actual flexion and extension ROM will be calculated by subtracting the lower inclinometer reading from the upper reading. |
Baseline , 2 weeks and 4 weeks post treatment
|
Samarbeidspartnere og etterforskere
Publikasjoner og nyttige lenker
Hjelpsomme linker
Studierekorddatoer
Studer hoveddatoer
Studiestart (Antatt)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- RE-166-2026
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
The result data collected de-identified individual participant data will be shared.
IPD-delingstidsramme
Six months after the publication of the manuscript.
Tilgangskriterier for IPD-deling
Data can be requested from the corresponding author.
IPD-deling Støtteinformasjonstype
- STUDY_PROTOCOL
- SEVJE
- ICF
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .